cs.MAAug 20, 2026

An Evidence-Grounded Multi-Agent System for High-Level Bio-Robot Design

Authors: Yujun Chen, Tianle Li, Jiayu Chen, Zhen Yin

Abstract

In this paper, a bio-robot is an engineered living or biohybrid system in which living cells perform one or more core functions, such as sensing, information processing, actuation or output. We focus on systems whose cell-based functions are programmed by genetic circuits; physical movement is optional. Designing such a system requires translating application requirements into sensing, logic or memory, output, assembly, host and containment modules, while grounding each choice in traceable parts and evidence. We present micro_biorobot_agent, an offline multi-agent system built on Qwen3.5-27B. The system combines requirement analysis, module-specific retrieval, candidate assembly, conflict checking, local repair, independent review and validation over an integrated library of 23,762 records covering biological parts, measured combinations, literature-supported relationships and actuation evidence. Deterministic output checks align the final report with the retrieved part set and correct false gaps, unsupported part mentions and source-tracking errors. On two author-developed evaluation sets of 50 queries each, the system obtains mean overall scores of 7.35 and 8.04, the highest among the seven evaluated systems; on Scenario Design it exceeds the runner-up by 2.23 points. A 50-query paired ablation shows that the source-tracking check reduces false-gap incidents from 15 to 3, an 80% reduction, and increases source accuracy by 0.75 points. This paper reports the Qwen3.5-based v1 system and evaluates high-level design reports rather than experimentally validated circuits.

Figures & tables

Explore similar work

May 7, 2026

BioResearcher: Scenario-Guided Multi-Agent for Translational Medicine

Translational medicine turns underspecified development goals into evidence synthesis that must combine literature, trials, patents, and quantitative multi-omics analysis while preserving identifiers, uncertainty, and retrievable provenance. General-purpose foundation models and off-the-shelf tool-augmented or multi-agent systems are not built for this: they tend to produce single-shot answers or run open-endedly, and fall short on the auditable, scenario-specific workflows that heterogeneous biomedical sources demand. This paper introduces Ingenix BioResearcher, a scenario-guided multi-agent system that maps queries to versioned research playbooks, delegates to specialized subagents over 30+ tools and machine-learning endpoints, mixes structured database access with sandboxed code for genome-scale analyses, and applies claim-level multi-model reconciliation before editorial assembly. We evaluate BioResearcher across unit-level capabilities, open-ended biomedical reasoning, and end-to-end clinical discovery. It leads evaluated baselines on 109 single-step tests (83.49% pass rate; 0.892 average score), achieves strong biomedical benchmark performance (89.33% on BixBench-Verified-50 and the top 0.758 mean score on BaisBench Scientific Discovery), and leads on a 30-query clinical end-to-end benchmark with the highest positive hit rate (74.7% ±\pm 3.3%) and negative clear rate (96.8% ±\pm 0.2%). These results show broad, competitive performance across unit-level, open-ended, and end-to-end clinical evaluations.
May 13, 2026

Do Biological Structural Guarantees Earn Their Complexity?

Biologically-inspired AI agent frameworks claim reliability benefits through structural guarantees adapted from gene regulatory networks, immune systems, and metabolic control. These claims are rarely tested empirically against simpler alternatives. We present three deep benchmarks: metabolic priority gating, autoinducer-based quorum sensing, and Bayesian stagnation detection, each comparing a biologically-grounded implementation against a naive non-biological alternative and an ablated control, across 1,000 trials per seed and 10 seeds (10M+ data points total).
Jun 19, 2026

BioInsight: Multi-Agent Orchestration for Interactive Biomedical Knowledge Discovery

Biomedical researchers increasingly use AI-generated analyses and reports to interpret protein-level signals, but static outputs are often insufficient for research decision-making, where users need to inspect evidence, assess uncertainty, compare mechanisms, and refine hypotheses. We present BioInsight, a multi-agent system that moves from static biomedical report generation to interactive evidence-centered interactive interface generation. Given a disease name, a protein association table, and optional cohort metadata, BioInsight organizes disease-specific evidence through typed intermediate artifacts, including ranked pathways, literature evidence packets, protein-level reasoning notes, citation-grounded reports, dashboard schemas, and rendered interactive interfaces. The system decomposes evidence retrieval from mechanistic reasoning, normalizes citations through deterministic components, and converts the same structured evidence used in the report into an interactive interface. We evaluate BioInsight on standardized biomedical QA, challenging protein-function reasoning, and end-to-end biomedical evidence synthesis. Results show that BioInsight achieves best, and suggest that biomedical AI systems should move beyond text-only and static reports toward provenance-preserving, interactive evidence artifacts.